摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-chlorononane | 28123-70-8

中文名称
——
中文别名
——
英文名称
5-chlorononane
英文别名
——
5-chlorononane化学式
CAS
28123-70-8
化学式
C9H19Cl
mdl
——
分子量
162.703
InChiKey
GHLDSOWZIOPMTC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    85-87 °C(Press: 14 Torr)
  • 密度:
    0.8639 g/cm3(Temp: 15 °C)
  • 保留指数:
    1092;1092

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    10
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

SDS

SDS:f1df77a3ea65caf336ca9bb7b55982d5
查看

反应信息

  • 作为反应物:
    描述:
    5-chlorononane 在 dibutyltin(II) dilaurate 、 联苯lithium 作用下, 以 四氢呋喃 为溶剂, 反应 52.0h, 生成
    参考文献:
    名称:
    Siloxanes from the hydrolysis of isopropyltrimethoxysilane
    摘要:
    The behavior of isopropyltrimethoxysilane (1) in the presence one equivalent of water and a dibutyltin dilaurate catalyst has been investigated. Under these conditions, partial hydrolysis of the methoxy groups of 1 occurred, followed by condensation reactions leading to the formation of low molecular-weight oligomers. Disiloxane 4, trisiloxane 6 and cyclic siloxanes 7 and 8 have been isolated and fully characterized. Transient reaction intermediates silanol 3 and hydroxydisiloxane 5 have been characterized spectroscopically, The time evolution of these species was followed by gas chromatography and Si-29 NMR. A reaction scheme for the hydrolytic condensation of 1 is proposed to accommodate these results.
    DOI:
    10.1016/0022-328x(94)05159-9
  • 作为产物:
    描述:
    5-bromononanemagnesium 作用下, 生成 5-chlorononane
    参考文献:
    名称:
    Grignard; Ono, Bulletin de la Societe Chimique de France, 1926, vol. <4> 39, p. 1593
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Enantioselective Three-Component Fluoroalkylarylation of Unactivated Olefins through Nickel-Catalyzed Cross-Electrophile Coupling
    作者:Hai-Yong Tu、Fang Wang、Liping Huo、Yuanbo Li、Shengqing Zhu、Xian Zhao、Huan Li、Feng-Ling Qing、Lingling Chu
    DOI:10.1021/jacs.0c03708
    日期:2020.5.27
    A nickel-catalyzed, enantioselective, three-component fluoroalkylarylation of unactivated alkenes with aryl halides and perfluoroalkyl iodides has been described. This cross-electrophile coupling protocol utilizes a chiral nickel/BiOx system as well as a pendant chelating group to facilitate the challenging three-component, asymmetric difunctionalization of unactivated alkenes, providing direct access
    镍催化、对映选择性、三组分氟烷基芳基化未活化的烯烃与芳基卤化物和全氟烷基碘化物已被描述。这种交叉亲电偶联方案利用手性镍/BiOx 系统以及悬垂的螯合基团来促进未活化烯烃的具有挑战性的三组分不对称双官能化,从而以高效和出色的对映选择性直接获得有价值的手性 β-氟烷基芳基烷烃. 温和的条件允许广泛的底物范围以及良好的官能团耐受性。
  • [EN] TLR-AGONIST-CONJUGATED ANTIBODY RECRUITING MOLECULES (TLR_ARMS)<br/>[FR] MOLÉCULES DE RECRUTEMENT D'ANTICORPS CONJUGUÉS À UN AGONISTE DE TLR)
    申请人:UNIV YALE
    公开号:WO2013166110A1
    公开(公告)日:2013-11-07
    The present invention relates to chimeric chemical compounds which are used to recruit antibodies to cancer cells, in particular, prostate cancer cells or metastasized prostate cancer cells. The compounds according to the present invention comprise an antibody binding terminus (ABT) moiety covalently bonded to a cell binding terminus (CBT) and Toll-like receptor agonist (TLR) through a linker and a multifunctional connector group or molecule.
    本发明涉及嵌合化学化合物,用于招募抗体到癌细胞,特别是前列腺癌细胞或转移的前列腺癌细胞。根据本发明的化合物包括一个与细胞结合末端(CBT)和通过连接物和多功能连接组或分子共价结合的抗体结合末端(ABT)基团和Toll样受体激动剂(TLR)。
  • TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)
    申请人:YALE UNIVERSITY
    公开号:US10016412B2
    公开(公告)日:2018-07-10
    The present invention relates to chimeric chemical compounds which are used to recruit antibodies to cancer cells, in particular, prostate cancer cells or metastasized prostate cancer cells. The compounds according to the present invention comprise an antibody binding terminus (ABT) moiety covalently bonded to a cell binding terminus (CBT) and Toll-like receptor agonist (TLR) through a linker and a multifunctional connector group or molecule.
    本发明涉及用于将抗体募集到癌细胞,特别是前列腺癌细胞或转移的前列腺癌细胞的嵌合化学化合物。根据本发明的化合物包括抗体结合末端(ABT)分子,通过连接体和多功能连接基团或分子与细胞结合末端(CBT)和Toll样受体激动剂(TLR)共价键合。
  • Schlenk,W., Justus Liebigs Annalen der Chemie, 1973, p. 1156 - 1178
    作者:Schlenk,W.
    DOI:——
    日期:——
  • Über hochverzweigte aliphatische Verbindungen
    作者:Friedrich Kuffner、Sonja Sattler-Dornbacher、Walter Seifried
    DOI:10.1007/bf00903144
    日期:1962.3
查看更多